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Choosing the appropriate patient for surgery is crucial for good outcome in total hip arthroplasty (THA). Therefore, parameters
predicting outcome preoperatively are of major interest. In the current study, we compared the predictive power of different
presurgical measures in minimally invasive THA. In the course of a prospective clinical trial preoperative HOOS, EQ-5D and SF-36
were obtained in 140 patients undergoing THA. Responder rate was defined by the modified OMERACT-OARSI criteria at six-
month-, one-year, two-year, and three-year follow-up. Logistic regression was performed to compare the different questionnaires
regarding their power of predicting positive responders. ROC-curve analysis was used to define benchmarks in preoperative
measures associatedwith good outcome. PreoperativeHOOS (p<0.001), EQ-5D (p=0.007), and PCS of SF-36 (p<0.001) were higher
in responders than in nonresponders whereas no differences between responders and nonresponders were found for preoperative
MCS (p=0.96) of SF-36.However, preoperativeHOOS revealed best predictive power (OR=0.84 95%CI=0.78-0.90, p<0.001, Pseudo
R-Squared according to Nagelkerke=0.48, effect size according to Cohen=0.96) compared to all other preoperative measures.
Multivariable analysis confirmed preoperative HOOS as an independent parameter correlating with postoperative responder status
(OR=0.76, 95% CI=0.66–0.88, p<0.001). In ROC-curve analysis nonresponders were identified with a sensitivity of 91.7% and
specificity of 68.9% using a cutoff in preoperative HOOS of 40.3. Presurgical HOOS can predict outcome in THA better than other
preoperative outcome measures. Patients with a preoperative HOOS value less than 40.3 have the highest probability of a positive
response in terms of pain and function after THA.
1. Introduction
Total hip arthroplasty (THA) is one of the most frequently
performed procedures in orthopaedic surgery [1]. It repre-
sents a curative treatment option of advanced hip arthritis
with the capacity to substantially improve quality of life
[2]. For primary THA an increase of 174% is estimated
in the United States by 2030 [3]. The high demand for
THA is faced with restricted clinical resources, thus leading
to prolonged wait times and even a potential supply side
crisis [4, 5]. Despite all technical advances in THA over the
last decades, there is still a certain number of dissatisfied
patients with residual pain and function deficits regarding
the postoperative outcome after THA [6]. Therefore, it is of
great interest in orthopaedic surgery to identify predictors for
good outcome. This might facilitate handling the indication
of THAwith high responsibility and choosing the appropriate
patients for surgery especially in times of limited resources.
Patient-reported preoperative measures (PROMs) have rou-
tinely been introduced by the national health systems and
quality networks to ensure clinical standards and supervise
outcome after THA [7, 8]. Originally PROMs were designed
for clinical studies and were shown to measure outcomes
after THA with high validity and reliability [9, 10]. Although
PROMs were not developed to predict outcomes, different
studies showed an association between presurgical values
of these questionnaires and postoperative outcomes [2, 11–
13]. However, the discussion in literature is controversial
[14, 15]. In the current single center study we evaluated
three of the most commonly used presurgical measures in
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THA regarding their ability to predict postoperative outcome
in THA. We asked which preoperative measure shows the
best correlation to positive responders after THA at a high
volume center for arthroplasties. Second, we tried to define
preoperative benchmark values for the best preoperative
measure to identify good responders in THA with a high
sensitivity.
2. Patients and Methods
In the course of a prospective clinical trial, 140 patients
underwent minimally invasive THA. The investigation was
registered in the Clinical Trial Register (DRKS00000739,
German Clinical Trials Register) and approved by the local
ethics commission. According to the protocol of the main
study [16, 17], eligible participants were patients between the
ages of 50 and 75 years with an American Society of Anaes-
thesiologists (ASA) score of 3 or belowwhowere admitted for
primary cementless unilateral THAattributable to primary or
secondary osteoarthritis. Exclusion criteria were age younger
than 50 years (as a postoperative CT scan was required) and
older than 75 years (to ensure postoperative follow-up was
achieved), ASA score greater than 3, arthritis attributable to
hip dysplasia, posttraumatic hip deformities, and previous
hip surgery. Only patients who had no significant disease
of the contralateral hip were included. Because of the strict
inclusion criteria, of 783 patients screened, 597 did not
meet the inclusion criteria. Twenty-seven patients declined
to participate and 19 were excluded for other reasons (e.g.,
cancellation of the operation owing to elevated inflammatory
markers).
Prior to participation in the study a written informed
consent was obtained. THA was performed with all patients
in the lateral decubitus position using a minimally invasive
single-incision anterolateral approach by four experienced
orthopaedic surgeons, three of which are among the coau-
thors (MWo, JG, TR) in our Department of Orthopaedic
Surgery, Regensburg University Medical Center, Bad Abbach,
Germany. Press-fit acetabular components and cement-free
hydroxyapatite-coated stems (Pinnaclecup, Corailstem;
DePuy, Warsaw, IN, USA) with metal heads of 32mm
were used. Of the initially 140 patients, four withdrew their
informed consent and thus had to be excluded. For one
further patient, preoperative questionnaires were incomplete,
and for one patient a cemented stem had to be used due
to severe osteoporosis, leaving 134 patients. For six-month
follow-up 128, for one-year 126, for two-year 126, and for 3-
year 125 patients were available to define responder status
(Figure 1). Anthropometric characteristics of the study group
are shown in Table 1.
Preoperatively measures such as the Hip Disability and
Osteoarthritis Outcome Score (HOOS) [18], EuroQol (EQ-
5D) [19], and the Short Form 36 questionnaire (SF-36)
[20] were obtained. These scores are usually obtained to
measure outcome after THA. In this study we only used the
preoperative values of these scores to investigate which score
is best at predicting patients with good outcome after THA.
The HOOS was developed to measure outcome in patients
with hip osteoarthritis. All Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) [21] questions
are included in the HOOS. In addition to WOMAC, HOOS
contains subscales for sport and recreation function resulting
in a better responsiveness especially in younger patients [22].
The HOOS consists of 5 subscales: pain, symptoms, activities
of daily living, sport, and quality of life built by 40 items.
For standardized answers five Likert-boxes are available. The
best scale is 100 points indicating no problems [9]. The EQ-
5D is a widely used and tested descriptive instrument for
evaluating health. It defines health based on five dimen-
sions: Mobility, Self-Care, Usual Activities, Pain/Discomfort,
and Anxiety/Depression. Each dimension has 3 response
categories ranging from no problems and some problems
to extreme problems. The EQ-5D was tested in general
population and patient samples for valuing health [23]. The
SF-36 is a common general health scale evaluating physical
and mental health. It measures three major health attributes
such as functional status, well-being, and overall health in
eight subscales. These consist of physical function, pain,
health, vitality, social function, emotional health, and mental
health. The responses of the 36 questions are transferred to
0-100 worst/best scale whereas 50 points correspond to a
general healthy population [20, 24]. To generate summary
scores country specific weights were generated. As a result,
the Physical Component Summary (PCS) and the Mental
Component Summary (MCS) can be built [25].
For dichotomizing responders and nonresponders at
each follow-up point after THA, the Outcome Measures in
Rheumatology and Osteoarthritis Research Society Inter-
national (OMERACT-OARSI) consensus responder criteria
were used [26, 27]. Responder status was defined separately
for each follow-up point. The OMERACT-OARSI criteria
assess responder status based on relative change inWOMAC
scores in relation to benchmarks determined by expert
consensus and statistical analyses. The WOMAC itself is an
international widely used score to evaluate outcome after total
joint replacement representing a multidimensional measure
of pain, stiffness, and physical functional disability [28].
This measurement of outcome has especially been developed
for patients with osteoarthritis and has been approved in
several longitudinal studies with patients undergoing total
joint replacement [29–31]. For defining responders we chose
the OMERACT-OARSI criteria since they do not depend
on patient characteristics of the cohort, thus reducing any
potential selection bias [32]. The OMERACT-OARSI crite-
ria to assess responders after total joint replacement were
previously described [2, 33]. Due to the low numbers of
true nonresponders, we set the OMERACT-OARSI criteria
stricter to define patients with high response after THA.
The modified criteria defined a patient as a responder if all
single requirements of the OMERACT-OARSI criteria [26]
were met at the same time. This comprised improvement
in pain and function of at least 50% and absolute change
of at least 20 points. Therefore, our modified criteria impli-
cate high improvement in both pain and function posto-
peratively.
For statistical analysis, continuous data are presented as
median (range) due to nonnormal distribution of presurgical
measures. Accordingly, group comparisons were performed
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Table 1: Anthropometric and operative characteristics of the study group classified in responder grade one year after THA∗.
N=126 Responders Non-Responders#
Age (years) 61.6 ± 7.4 64.2 ± 8.2
Gender (men/women) 51/52 12/11
BMI (kg/m2) 27.0 ± 4.1 26.6 ± 3.5
Treatment side (left/right) 48/55 11/12
ASA Class 1 18 (17.5%) 7 (30.4%)
ASA Class 2 53 (51.5%) 12 (52.2%)
ASA Class 3 32 (31.1%) 4 (17.4%)
Kellgren–Lawrence score 9 (5–10) 8 (7–9)
Length of skin incision (cm) 10.4 ± 1.2 10.2 ± 1.4
Operative time (minutes) 68.7 ± 14.7 66.3 ± 13.7
∗ For categorical data, values are given as relative and absolute frequencies; for quantitative data, values are given as mean (standard deviation) or median
(range). # Responders and nonresponders were defined according to the modified OMERACT-OARSI criteria. THA: total hip arthroplasty, BMI: body mass
index, ASA: American Society of Anaesthesiologists.
Screening
Assessed for eligibility (n=783)
Inclusion (n=140)
Allocation
Preoperative questionnaires and cementless MIS 
THA (n=134)
Did not receive allocated intervention (n=6)
• One patient with incomplete questionnaires
• One patient with a cemented stem
• Four patients withdrew informed consent
Clinical Follow-Up
• 6 months after surgery (n=128)
• 1 year after surgery (n=126)
• 2 years after surgery (n=126)
• 3 years after surgery (n=125)
• Not meeting inclusion criteria (n=597) 
• Declined to participate (n=27)
• Other reasons (n=19)
Figure 1: Flow diagram of the study participants.
using Mann-Whitney U-tests. Absolute and relative frequen-
cies were given for categorical data and compared between
groups by chi-square tests. Logistic regression was per-
formed for preoperative measures with significant differences
between responders and nonresponders (HOOS, EQ-5D,
PCS) to evaluate sensitivity in predicting responders at each
follow-up point after surgery. To allow a direct comparison
between the different scores in the regression models the EQ-
5D index value was transformed to a 0-100 scale by multiply-
ing by 100. Pseudo R-Squared according to Nagelkerke and
Cohen effect size were calculated to evaluate the quality of
each model. A Cohen value of 0.01 represents a weak effect,
a value of 0.25 a middle effect, and a value of 0.4 a strong
effect, respectively [34]. Furthermore, odds ratios (OR) were
4 BioMed Research International
EQ-5D HOOS PCS MCS
Responder 1 year
Non Responder
Responder






Figure 2: Preoperative measures (HOOS, EQ-5D, PCS, MCS)
for responders and nonresponders assessed one year after total
hip arthroplasty. EQ-5D∘: EuroQol multiplied by 100, HOOS:
Hip Disability and Osteoarthritis Outcome Score, PCS: Physical
Component Summary of the Short Form 36 questionnaire, MCS:
Mental Component Summary of the Short Form 36 questionnaire.
compared between the preoperatively obtained measures.
Afterwards a multivariable logistic regression model includ-
ing age, gender, ASA, BMI, operative time, Kellgren Score
ranging from 0 to 10 points, (grade 0 = 0 points, grade 1= 1-
2 points, grade 2 = 3-4 points, grade 3 = 5-9 points, grade 4
= 10 points), length of skin incision, preoperative pain level,
and preoperative expectations was calculated to test the inde-
pendent correlation of the best score with one-year responder
rate.Then receiver operating characteristic (ROC) curve plots
were generated for each follow-up point (6 months, 1 year,
2 years, 3 years). The Youden Index was used to define
benchmarks to predict outcome after THA with the help
of preoperative measures. The Youden indices, sensitivity,
specificity, and area under the curve (AUC) were compared
between the different follow-up points. IBM SPSS Statistics
22 (SPSS Inc., Chicago, IL, USA) was used for analysis.
3. Results
Using the stricter modified OMERACT-OARSI criteria [26]
one year after THA, we found 103 responders and 23 nonre-
sponders. Preoperative HOOS (p<0.001), EQ-5D (p=0.007)
and PCS of SF-36 (p<0.001) were higher in responders than
in nonresponders whereas no differences between respon-
ders and nonresponders were found for preoperative MCS
(p=0.96) of SF-36 (Figure 2). For the preoperative HOOS,
EQ-5D, and PCS, this held also true for 6 month-, two-year,
and three-year responders (Table 2).
Since HOOS, EQ-5D, and PCS showed significant dif-
ferences between responders and nonresponders, binary
regression analyses were performed for these questionnaires.
Analyzing the relation to responder grade one year after
THA, preoperative HOOS revealed best Pseudo R-Squared
according to Nagelkerke with 0.48 and a corresponding effect
size according to Cohen with 0.96. Similarly, OR showed the
strongest correlation between responder status one year after
surgery and preoperative HOOS with 0.84 (95% CI = 0.78 -
0.90, p<0.001) compared to other presurgical measures. This
held true for all follow-up points (Table 3).
Therefore, we chose the preoperative HOOS as the ques-
tionnaire with the best correlation to responder status and
generated amultivariable analysis including different possible
confounders. The results revealed preoperative HOOS as
an independent parameter correlating with postoperative
responder status (OR = 0.76, 95% CI = 0.66 – 0.88, p<0.001)
whereas all other variables showed no association (Table 4).
To define cutoff values for HOOS to predict postoperative
outcome one year after surgery, a ROC-curve plot was
generated (AUC=0.88, 95%CI= 0.80 –0.96). Analyzing one-
year nonresponders, Youden Index was highest with 0.61 for a
benchmark HOOS value of 40.3.This resulted in a sensitivity
of 91.7% and specificity of 68.9% to identify nonresponders.
Accordingly, the negative predictive value was 97.4% and the
positive predictive value 39.7%. To test the validity of the
cutoff, ROC-curve analysis for other follow-up points was
performed (Figure 3). Nonresponders as defined 3 years after
surgery were predictable with a sensitivity of 80.8% and a
specificity of 67.0% using a cutoff for preoperative HOOS of
40.3.
4. Discussion
THR is a frequently performed procedure in orthopaedic
surgery [2, 35]. Since clinical resources are limited [5], pre-
operative predictors of outcome for THR play an important
rolewhen counselling patients in the office [12]. In the current
study, we aimed (1) to analyze different preoperativemeasures
regarding their ability to predict outcome and (2) to define
benchmarks for preoperative measures to identify patients
preoperatively associated with high improvement after THA.
We found the preoperative HOOS as the questionnaire with
the highest predictive power among all other preoperative
measures. A cutoff HOOS value of 40.3 resulted in a sensitiv-
ity of 91.7%and specificity of 67.9% to identify nonresponders
after THA.
In answer to the first question of the study, which
preoperative measure shows the best association to positive
responder status after THA, we found a difference in pre-
operative scores (HOOS, EQ-5D, PCS) between responders
and nonresponders as defined by the modified OMERACT-
OARSI criteria after THA. Preoperative HOOS, EQ-5D, and
PCSwere consistently different between responders and non-
responders for all follow-up points. In contrast, preoperative
mental health asmeasured in theMCS showed no association
with responder status as defined at the different follow-up
points. This is in line with previous studies revealing a corre-
lation between high preoperative measures and worse clinical
outcome after joint replacement [11, 12]. However, not all
preoperative measures seem to have this predictive effect [15].
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Table 2: Comparison of presurgical measures in relation to responder status defined separately for each follow-up point ∗.
Responder Status HOOS EQ-5D PCS MCS
6 months
n=128
Non-Responder
median 49.4 0.79 33.1 38.0
range 22.5 0.11 16.0 -26.0
77.5 0.89 49.0 82.0
Responder
median 35.0 0.70 26.5 38.0
range 1.9 0.11 14.0 -40.0
58.8 1.00 44.0 82.0
p <0.001 0.06 <0.001 0.46
1 year
n=126
Non-Responder
median 52.9 0.79 34.4 48.0
range 30.0 0.18 24.0 -6.0
77.5 0.89 49.0 82.0
Responder
median 35.0 0.70 26.7 38.0
range 1.9 0.11 14.0 -40.0
58.8 1.00 44.0 82.0
p <0.001 0.01 <0.001 0.96
2 years
n=126
Non-Responder
median 50.0 0.79 32.7 48.0
range 22.5 0.11 16.0 -26.0
77.5 0.89 49.0 82.0
Responder
median 35.0 0.70 26.8 38.0
range 1.9 0.11 14.0 -40.0
64.4 1.00 44.0 82.0
p <0.001 0.01 0.001 0.73
3-years
n=125
Non-Responder
median 48.8 0.79 32.9 53.0
range 31.3 0.18 16.0 3.0
77.5 0.89 49.0 82.0
Responder
median 35.0 0.70 26.5 38.0
range 1.9 0.11 14.0 -40.0
64.4 1.00 44.0 82.0
p <0.001 0.002 <0.001 0.36
∗ For quantitative data, values are given as median and range. HOOS: Hip Disability and Osteoarthritis Outcome Score, EQ-5D: EuroQol, PCS: Physical
Component Summary of the Short Form 36 questionnaire, MCS: Mental Component Summary of the Short Form 36 questionnaire, p: p-value.
On the other hand patients with poor preoperative function
have high expectations of THA [36]. This might result in
unrealistic expectations and thus dissatisfaction after surgery.
However, greater numbers of preoperative expectations were
reported in literature to be associated with improvement
after THA [37]. In contrast to our study results, a previous
study described a correlation between preoperative MCS and
responder status. However, a different cohort dependent def-
inition for good outcomewas used (MID) [11]. Another study
found no correlation between preoperative MCS and postop-
erative responder grade. This study used the lowest quartile
criteria [6]. The reason why there was no relation between
preoperative MCS and responder status in our study might
rely on the applied definition of responder. Since the defini-
tion is mainly based on parameters of physical function, psy-
chological effects might not be accounted for appropriately.
Among the different preoperative measures preoperative
HOOS showed the highest predictive power for positive
responder as defined at all follow-up points as measured by
logistic regression analysis. In literature parameters associ-
ated with outcome after THA such as gender, age, Kellgren
Score, pain, or ASA class have been described. In the present
study, the correlation of preoperative HOOS and responder
status was independent of these potential confounders as
demonstrated by multivariable analysis. Neither gender, age,
Kellgren Score, pain nor ASA class correlated with respon-
der status after THA. In contrast to our results, women
and patients at an advanced age were previously described
in literature to be associated with lower improvement in
physical function [12, 38], whereas more severe radiographic
degeneration preoperatively correlated with better functional
outcome after THA in former studies [12, 38]. Patient comor-
bidity and number of troublesome joints also correlated with
responder grade after total joint replacement [11]. Previous
trauma [12] and higher preoperative pain [6] were reported
as risk factors for worse outcome. However, due to the strict
inclusion criteria of the present study, these parameters have
not been addressed.
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Table 3: Binary logistic regression for each presurgical measure for responder at each follow-up after THA.
R-Squared Eﬀect Size OR 95% CI P-value
6 months
HOOS 0.34 0.72 0.89 0.84 0.93 <0.001
EQ-5D∘ 0.05 0.23 0.99 0.97 1.00 0.06
PCS 0.19 0.48 0.89 0.83 0.95 <0.001
1 year
HOOS 0.48 0.96 0.84 0.78 0.90 <0.001
EQ-5D∘ 0.09 0.31 0.98 0.96 1.00 0.01
PCS 0.27 0.61 0.86 0.79 0.92 <0.001
2 years
HOOS 0.40 0.82 0.87 0.82 0.92 <0.001
EQ-5D∘ 0.08 0.29 0.98 0.96 1.00 0.02
PCS 0.16 0.44 0.90 0.84 0.96 0.001
3 years
HOOS 0.35 0.73 0.88 0.83 0.93 <0.001
EQ-5D∘ 0.11 0.35 0.97 0.95 0.99 0.01
PCS 0.17 0.45 0.89 0.84 0.95 0.001
THA: total hip arthroplasty, OR: odds ratio, CI: confidence interval, HOOS: Hip Disability and Osteoarthritis Outcome Score, EQ-5D∘ : EuroQol multiplied by
100, PCS: Physical Component Summary of the Short Form 36 questionnaire.
Table 4: Multivariable analysis of risk factors associated with responder grade one year after THA.
Responder OR 95% CI P-value
HOOS 0.76 0.66 0.88 <0.001
Gender 0.87 0.20 3.81 0.86
Age 0.92 0.83 1.03 0.13
ASA 1.18 0.37 3.75 0.78
BMI 0.85 0.67 1.07 0.17
Operative time 1.01 0.95 1.08 0.77
Kellgren–Lawrence score 1.82 0.72 4.64 0.21
Length of skin incision 0.84 0.43 1.65 0.61
THR 0.99 0.94 1.04 0.71
VAS 5.56 0.03 1220.58 0.53
MCS 1.04 0.98 1.11 0.20
THA: total hip arthroplasty, OR: odds ratio, CI: Confidence Interval, HOOS: Hip Disability and Osteoarthritis Outcome Score, ASA: American Society of
Anaesthesiologists, BMI: bodymass index, THR: Total Hip Replacement Expectations Survey, VAS: visual analogue scale, MCS: Mental Component Summary
of the Short Form 36 questionnaire.
Researching into a benchmark to distinguish between
responders and nonresponders, ROC-curve analysis showed
a good discriminatory ability with an AUC of 0.88. For a
cutoff of 40.3 in preoperativeHOOS, the sensitivity was 91.7%
and the specificity 68.9%. Therefore, patients with a lower
preoperative HOOS value than 40.3 have a high probability
for excellent improvement in pain and function if undergoing
THA.This should be considered when counselling patients in
the office since theHOOS is easy to obtain in the preoperative
situation. Comparing a different predictive model stated in
literature, there was an AUC of 0.76 with a sensitivity of
66.1% and specificity of 74.3% [12]. SF-36 physical function
score, sex, age, radiographic grade, previous hip injury, and
number of painful joints were included in this clinical risk
scoring tool [12]. In a different study, gait analysis was
used to predict clinical response after THA. In combination
with preoperative HHS, nonresponders were identified with
a sensitivity of 71.4% and specificity of 99.1% [32]. Due
to our definition of positive responder comprising a high
improvement in both pain and function, we aimed to create
a model with a high negative predictive value. The negative
predictive value in our study was 97.4%.This means a patient
with a preoperative HOOS below 40.3 has a probability of
97.4% for a positive response after THA. This could facilitate
handling medical indication of THA for the orthopaedic
surgeon when counselling patients in the office. The low
positive predictive value of 39.7% shows that a HOOS value
above 40.3 does not necessarily mean a patient will not
become a responder after surgery. However, this was not
the intention of our study since we focused on an easily
applicable tool to identify patients benefitting best from
THA.
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Figure 3: ROC-curve analysis for nonresponder at the different follow-up points using preoperative HOOS.
There are several limitations of this study. First, the
results depend on the applied definition of responder status
after THA. To minimize potential bias, we chose patient
characteristics independent dichotomization for responders
in contrast to cohort dependent dichotomization such as
lowest quartile or minimal important difference (MID).
Using non-cohort dependent benchmarks should maximize
generalizability [32]. According to the applied definition of
responder grade which is mainly based on physical function,
the results might be susceptible to potential bias. Second,
due to the low numbers of nonresponders according to
the original OMERACT-OARSI criteria [26], we set the
requirements stricter. Therefore according to this defini-
tion, a positive responder status means patients with high
improvement in both function and pain after THA. Third,
the current analysis is restricted to the information provided
by the data collected during the course of the study. More
detailed information on the patient’s psychological or social
status might have an impact on the patient specific outcome
and improve prediction of outcome. Fourth, for the current
analysis only mid-term outcome data for the first 3 years are
available. It would have been of interest to include long-term
outcome and failure rates. Fifth, due to the strict inclusion
and exclusion criteria of the main study, the study population
represents a highly selected patient subgroup. Therefore, the
results cannot be automatically transferred to each individual
patient undergoing THR. A strength of the study is the fact
that all data refer to one single university medical center
reflecting a specific operative workflow for THA as well as
an identical postoperative treatment protocol for all patients.
Similarly, components of a singlemanufacturerwere used. All
this contributes to minimizing confounding factors.
5. Conclusions
In conclusion, presurgical HOOS can predict outcome better
than other preoperative outcome measures in this selected
group of patients undergoing THA. According to the applied
8 BioMed Research International
definition of responder, the preoperative HOOS showed the
best predictive power. Patients with a preoperative HOOS
above 40.3 could be identified as nonresponders with a
sensitivity of 91.7% and a specificity of 68.9%. Therefore,
preoperative HOOS should be considered when counselling
patients in the office. Further studies are required to reveal
the generalizability of the study results.
Data Availability
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available from the corresponding author upon request.
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